Young-Joo Jin

9PUBLICATIONS
104CO-AUTHORS
PharmacogenomicsDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 08, 2026
Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C.

|Jul 17, 2025
Temporal Dynamics and Treatment Outcomes of Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Multicenter Retrospective Study from South Korea.

Jae Yoon Jeong, Su Jong Yu, Jeayeon Park

|May 06, 2024
Clinical outcomes of transarterial chemoembolization in Child-Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma.

Jungnam Lee, Young-Joo Jin, Seung Kak Shin

|Mar 22, 2022
A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients.

Hyung Joon Kim, Ju Hyun Kim, Jong Eun Yeon

|May 31, 2021
Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials.

Jeong Heo, Yoon Jun Kim, Jin-Woo Lee

|May 27, 2020
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase.

Han Ah Lee, Hyun Woong Lee, In Hee Kim

Pageof 2

Frequent Collaborators

3 joint publications

Byoung Kuk Jang

3 joint publications

Soo Young Park

3 joint publications

In Hee Kim

3 joint publications

Yeon Seok Seo